Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (281)	8/3/1999 1:16:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 3158

(DAK pointed to your post today) HMR: ARIA-- HOE of course, Hoechst Marion Roussel, yeah, I like it. Merck, Sibia...I've just printed that out, well done Peter. I never really believed the note on Yahoo that Berger wanted 500M from Amgen for ARGENT, but Ariad would fit nicely into Aventis later on-- maybe a third of that price? Especially considering they're a big shareholder already, preferred stock I think. But I have another one to suggest tonight, tell me what you folks think. AFFX: GLGC, Gene Logic. I guess it all depends on the Flow Through chip-- but maybe not, maybe at this price affy would swallow them just for GeneExpress... disclaimer...yes, I did put my Sibia profits into another 1000 of GLGC today.... And with that...good night everybody... I've work to do. --Capn' Midnight.